Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02376127 · ClinicalTrials.gov registry record
Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion
A clinical trial of Solid Cancer and Metastatic Spinal Lesions, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT02376127: Completed study of Solid Cancer and Metastatic Spinal Lesions, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02376127 is a study of Solid Cancer and Metastatic Spinal Lesions that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02376127, a study of Solid Cancer and Metastatic Spinal Lesions, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess imaging methods including Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) and perfusion for the cancer that has spread to the spine. The study aims to see if using these methods will help better see response to treatment with radiation in patients with spine metastases from any solid cancer.
Primary Outcome
will be based on clinical assessment and conventional MRI and PET imaging, evaluating images for evidence of tumor contraction and stable disease for more than 11 months. Clinical assessment is done by radiation oncology and is based on physical examination, patient symptoms and consideration of radiological studies.
Conditions Studied
Interventions
- PROCEDURE Dynamic contrast enhancement MRI
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-02-24 |
| Est. Completion | 2025-07-16 |
What the finished NCT02376127 record still lists
NCT02376127 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 2 conditions, with Solid Cancer appearing as the primary indexed condition, and to 1 intervention - of which Dynamic contrast enhancement MRI is the first listed.
NCT02376127 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02376127 about?
NCT02376127 is a clinical study titled "Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion". The purpose of this study is to assess imaging methods including Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) and perfusion for the cancer that has spread to the spine. The study aims to see if using these methods will help better see response to treatment with radiation in patient...
What is the current status of trial NCT02376127?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2015-02-24. Estimated completion is 2025-07-16.
What conditions does trial NCT02376127 study?
This clinical trial studies the following conditions: Solid Cancer, Metastatic Spinal Lesions.
What interventions are being tested in trial NCT02376127?
The interventions under investigation include: Dynamic contrast enhancement MRI (PROCEDURE).
Who is sponsoring clinical trial NCT02376127?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02376127 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI